Congratulations to Muhammed Murtaza who was awarded a a three-year, $1 million Exploratory/Developmental Cooperative Agreement Phase II (UH3) Award from the National Cancer Institute.
Congratulations to Muhammed Murtaza who was recently awarded a three-year, $1 million Exploratory/Developmental Cooperative Agreement Phase II (UH3) Award from the National Cancer Institute. The grant will support his study titled “Treatment monitoring in early and locally advanced breast cancer using circulating tumor DNA analysis.” Read more.
Patients with early-stage breast cancer and those who are diagnosed with locally advanced breast cancer are often treated with a combination of pre-operative therapy, surgical removal of the tumor, and post-operative therapy. However, many patients …